Chemclin Diagnostics Co., Ltd. (688468.SS)
CNY 7.26
(0.55%)
CNY 7.26
(0.55%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 166.28 Million CNY | -2.3% |
| 2022 | 170.29 Million CNY | 4.74% |
| 2021 | 162.58 Million CNY | 18.8% |
| 2020 | 136.85 Million CNY | -14.32% |
| 2019 | 159.73 Million CNY | 138.73% |
| 2018 | -412.4 Million CNY | 1.87% |
| 2017 | -420.24 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 42.61 Million CNY | 42.68% |
| 2024 Q2 | 37.42 Million CNY | -12.19% |
| 2024 Q3 | 43.19 Million CNY | 15.42% |
| 2023 Q1 | 38.9 Million CNY | 7.1% |
| 2023 FY | 166.37 Million CNY | -2.3% |
| 2023 Q4 | 29.86 Million CNY | -41.29% |
| 2023 Q3 | 50.87 Million CNY | 8.87% |
| 2023 Q2 | 46.73 Million CNY | 20.12% |
| 2022 Q3 | 57.2 Million CNY | 78.4% |
| 2022 Q2 | 32.06 Million CNY | -28.25% |
| 2022 Q1 | 44.69 Million CNY | 14.2% |
| 2022 FY | 170.29 Million CNY | 4.74% |
| 2022 Q4 | 36.32 Million CNY | -36.5% |
| 2021 Q2 | 36.35 Million CNY | -18.26% |
| 2021 Q1 | 44.47 Million CNY | -4.93% |
| 2021 FY | 162.58 Million CNY | 18.8% |
| 2021 Q4 | 39.13 Million CNY | -8.17% |
| 2021 Q3 | 42.61 Million CNY | 17.24% |
| 2020 Q1 | 12.96 Million CNY | -70.49% |
| 2020 FY | 136.85 Million CNY | -14.32% |
| 2020 Q4 | 46.77 Million CNY | -10.0% |
| 2020 Q3 | 51.97 Million CNY | 106.76% |
| 2020 Q2 | 25.13 Million CNY | 93.93% |
| 2019 Q3 | 46.53 Million CNY | 0.0% |
| 2019 Q4 | 43.93 Million CNY | -5.59% |
| 2019 FY | 159.73 Million CNY | 138.73% |
| 2018 FY | -412.4 Million CNY | 1.87% |
| 2017 FY | -420.24 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Shanghai Runda Medical Technology Co., Ltd. | 646.8 Million CNY | 74.291% |
| Joinn Laboratories(China)Co.,Ltd. | 507.09 Million CNY | 67.208% |
| WuXi AppTec Co., Ltd. | 11.87 Billion CNY | 98.599% |
| Autobio Diagnostics Co., Ltd. | 1.36 Billion CNY | 87.825% |
| Thalys Medical Technology Group Inc. | -180.32 Million CNY | 192.216% |
| Guangzhou Kingmed Diagnostics Group Co., Ltd. | 759.76 Million CNY | 78.113% |